本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Day One Biopharmaceuticals Inc.

21.41
+0.01000.05%
盤後21.420.0100+0.05%17:50 EDT
成交量:236.76萬
成交額:5,070.64萬
市值:22.12億
市盈率:-20.59
高:21.44
開:21.43
低:21.40
收:21.40
52周最高:21.46
52周最低:5.64
股本:1.03億
流通股本:7,876.62萬
量比:0.71
換手率:3.01%
股息:- -
股息率:- -
每股收益(TTM):-1.0400
每股收益(LYR):-1.0400
淨資產收益率:-22.74%
總資產收益率:-14.64%
市淨率:5.01
市盈率(LYR):-20.59

資料載入中...

2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/24

重要事件披露

Form 8-K - Current report
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans